Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women

Journal of General Virology

Volumn 89, Issue 6, 2008, Pages 1380-1389

  Tornesello, Maria Lina ^a   Duraturo, Maria Luisa ^a   Giorgi Rossi, Paolo ^b   Sansone, Matilde ^c   Piccoli, Roberto ^c   Buonaguro, Luigi ^a   Buonaguro, Franco Maria ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Agency for Public Health   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEIN E6; PROTEIN E7; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN; VIRUS RNA;

ADULT; ARTICLE; CANCER RISK; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; ITALY; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SEXUAL BEHAVIOR; UTERINE CERVIX CYTOLOGY; VERRUCA VULGARIS; VIRUS ISOLATION; VIRUS STRAIN; AIDS RELATED COMPLEX; CLASSIFICATION; COMPARATIVE STUDY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PATHOLOGY; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; STANDARD; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS GENE; VIRUS INFECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; FOLLOW-UP STUDIES; GENES, VIRAL; HIV SEROPOSITIVITY; HIV-1; HUMAN PAPILLOMAVIRUS 16; HUMANS; ITALY; NEOPLASMS, SQUAMOUS CELL; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RISK ASSESSMENT; RNA, VIRAL; SEQUENCE ANALYSIS; UTERINE CERVICAL NEOPLASMS; VARIATION (GENETICS);

EID: 45949098782     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83553-0     Document Type: Article

References (44)

1. Ahdieh, L., Klein, R. S., Burk, R., Cu-Uvin, S., Schuman, P., Duerr, A., Safaeian, M., Astemborski, J., Daniel, R. & Shah, K. (2001). Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 184, 682-690.
2. Bernard, H. U., Calleja-Macias, I. E. & Dunn, S. T. (2006). Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 118, 1071-1076.
3. Bosch, F. X., Manos, M. M., Muñoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R. & Shah, K. V. (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87, 796-802.
4. Buonaguro, F. M., Tornesello, M. L., Buonaguro, L., Del Gaudio, E., Beth-Giraldo, E. & Giraldo, G. (1994). Role of HIV as cofactor in HPV oncogenesis: in vitro evidences of virus interactions. In Advanced Technologies in Research, Diagnosis and Treatment of AIDS and in Oncology, 1st edn, pp. 102-109. Edited by G. Giraldo, M. Salvatore, L. Chieco-Bianchi & E. Beth-Giraldo. Basel: Karger.
5. Cappiello, G., Garbuglia, A. R., Salvi, R., Rezza, G, Giuliani, M., Pezzotti, P., Suligol, B., Branca, M., Migliore, G. & other authors (1997). HIV infection increases the risk of squamous intra-epithelial lesions in women with HPV infection: an analysis of HPV genotypes. DIANAIDS Collaborative Study Group. Int J Cancer 72, 982-986.
6. Cardillo, M., Hagan, R., Abadi, J. & Abadi, M. A. (2001). CD4 T-cell count, viral load, and squamous intraepithelial lesions in women infected with the human immunodeficiency virus. Cancer 93, 111-114.
7. Castellsagué, X. & Muñoz, N. (2003). Chapter 3: cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31, 20-28.
8. Cerqueira, D. M., de Moraes, S., Camara, G. N., Amaral, F. A., Oyama, C. N., dos Santos, M. O. & Martins, C. R. (2007). High HPV genetic diversity in women infected with HIV-1 in Brazil. Arch Virol 152, 75-83.
9. Chaturvedi, A. K., Brinkman, J. A., Gaffga, A. M., Dumestre, J., Clark, R. A., Braly, P. S., Dunlap, K., Kissinger, P. J. & Hagensee, M. E. (2004). Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women. J Gen Virol 85, 1237-1241.
10. Clifford, G. M., Goncalves, M. A. & Franceschi, S. (2006). Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 20, 2337-2344.
11. Heard, I., Potard, V., Foulot, H., Chapron, C., Costagliola, D. & Kazatchkine, M. D. (2005). High rate of recurrence of cervical intraepithelial neoplasia after surgery in HIV-positive women. J Acquir Immune Defic Syndr 39, 412-418.
12. Hiller, T., Poppelreuther, S., Stubenrauch, F. & Iftner, T. (2006). Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification. Cancer Epidemiol Biomarkers Prev 15, 1262-1267.
13. IARC (1995). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 64, Human Papillomaviruses. International Agency for Research on Cancer.
14. Levi, J. E., Kleter, B., Quint, W. G., Fink, M. C., Canto, C. L., Matsubara, R., Linhares, I., Segurado, A., Vanderborght, B. & other authors (2002). High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 40, 3341-3345.
15. Luque, A. E., Jabeen, M., Messing, S., Lane, C. A., Demeter, L. M., Rose, R. C. & Reichman, R. C. (2006). Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J Infect Dis 194, 428-434.
16. Massed, L. S., Riester, K. A., Anastos, K. M., Fruchter, R. G., Palefsky, J. M., Burk, R. D., Burns, D., Greenblatt, R. M., Muderspach, L. I. & Miotti, P. (1999). Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr 21, 33-41.
17. Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. & Meijer, C. J. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348, 518-527.
18. Muñoz, N., Castellsagué, X., de Gonzalez, A. B. & Gissmann, L. (2006). Chapter 1: HPV in the etiology of human cancer. Vaccine 24 (Suppl. 3), S1-S10.
19. Poljak M., Marin, I. J., Seme, K. & Vince, A. (2002). Hybrid capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 25 (Suppl. 3), S89-S97.
20. Rezza, G., Giuliani, M., Branca, M., Benedetto, A., Migliore, G., Garbuglia, A. R., D'Ubaldo, C., Pezzotti, P., Cappiello, G. & other authors (1997). Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group. Eur J Epidemiol 13, 937-943.
21. Rezza, G, Giuliani, M., Serraino, D., Branca, M., Benedetto, A., Garbuglia, A., Ippolito, G. & Franceschi, S. (1998). Risk factors for cervical presence of human papillomavirus DNA among women at risk for IIIV infection. DIANAIDS Collaborative Study Group. Epidemiol Infect 121, 173-177.
22. Rowhani-Rahbar, A., Hawes, S. E., Sow, P. S., Toure, P., Feng, O., Dem, A., Dembele, B., Critchlow, C. W., N'Doye, I. & Kiviat, N. B. (2007). The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. J Infect Dis 196, 887-894.
23. Schlecht, N. F., Burk R. D., Palefsky, J. M., Minkoff, H., Xue, X., Massad, L. S., Bacon, M., Levine, A. M., Anastos, K. & other authors (2005). Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J Gen Virol 86, 2709-2720.
24. Sherman, M. E., Carreon, J. D. & Schiffman, M. (2006). Performance of cytology and human papillomavirus testing in relation to the menstrual cycle. Br J Cancer 94, 1690-1696.
25. Smith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R. & Clifford, G. M. (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121, 621-632.
26. Strickler, H. D., Palefsky, J. M., Shah, K. V., Anastos, K., Klein, R. S., Minkoff, H., Duerr, A., Massad, L. S., Celentano, D. D. & other authors (2003). Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 95, 1062-1071.
27. Sun, X. W., Kuhn, L., Ellerbrock, T. V., Chiasson, M. A., Bush, T. J. & Wright T. C., Jr (1997). Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 337, 1343-1349.
28. Tornesello, M. L., Buonaguro, F. M., Beth-Giraldo, E. & Giraldo, G. (1993). Human immunodeficiency virus type I tat gene enhances human papillomavirus early gene expression. Intervirology 36, 57-64.
29. Tornesello, M. L., Buonaguro, F. M., Meglio, A., Buonaguro, L.. Beth-Giraldo, E. & Giraldo, G. (1997). Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients. J Gen Virol 78, 2199-2208.
30. Tornesello, M. L., Buonaguro, F. M., Buonaguro, L., Salatiello, I., Beth-Giraldo, E. & Giraldo, G. (2000). Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas. J Gen Virol 81, 2969-2982.
31. Tornesello, M. L., Duraturo, M. L., Salatiello, I., Buonaguro, L., Losito, S., Botti, G., Stellato, G., Greggi, S., Piccoli, R. & other authors (2004). Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 74, 117-126.
32. Tornesello, M. L., Duraturo, M. L., Botti, G., Greggi, S., Piccoli, R., De Palo, G., Montella, M., Buonaguro, L & Buonaguro, F. M. (2006). Prevalence of alpha-papillomavirus genotypes in cervical intraepithelial neoplasia and cervical cancer in the Italian population. J Med Virol 78, 1663-1672.
33. Tornesello, M. L., Duraturo, M. L., Buonaguro, L., Vallefuoco, G., Piccoli, R., Palmieri, S. & Buonaguro, F. M. (2007). Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer 2, 1.
34. Tweddel, G., Heller, P., Cunnane, M., Multhaupt, H. & Roth, K. (1994). The correlation between HIV seropositivity, cervical dysplasia, and HPV subtypes 6/11, 16/18, 31/33/35. Gynecol Oncol 52, 161-164.
35. Vernon, S. D., Hart, C. E., Reeves, W. C. & Icenogle, J. P. (1993). The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res 27, 133-145.
36. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., Snijders, P. J., Peto, J., Meijer, C. J. & Muñoz, N. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12-19.
37. Wang, S. S. & Hildesheim, A. (2003). Chapter 5: viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr 31, 35-40.
38. Winship, P. R. (1989). An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic Acids Res 17, 1266.
39. Xi, L. F., Koutsky, L. A., Galloway, D. A., Kuypers, J., Hughes, J. P., Wheeler, C. M., Holmes, K. K. & Kiviat, N. B. (1997). Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89, 796-802.
40. Xi, L. F., Carter, J. J., Galloway, D. A., Kuypers, J., Hughes, J. P., Lee, S. K., Adam, D. E., Kiviat, N. B. & Koutsky, L. A. (2002). Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university Students. Cancer Epidemiol Biomarkers Prev 11, 343-351.
41. Xi, L. F., Kiviat, N. B., Hildesheim, A., Galloway, D. A., Wheeler, C. M., Ho, J. & Koutsky, L. A. (2006). Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst 98, 1045-1052.
42. Xi, L. F., Koutsky, L. A., Hildesheim, A., Galloway, D. A., Wheeler, C. M, Winer, R. L., Ho, J. & Kiviat, N. B. (2007). Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 10 and 18. Cancer Epidemiol Biomarkers Prev 16, 4-10.
43. Yamada, T., Manos, M. M., Peto, J., Greer, C. E., Muñoz, N., Bosch, F. X. & Wheeler, C. M. (1997). Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71, 2463-2472.
44. zur Hausen, H. (1987). Papillomaviruses in human cancer. Appl Pathol 5, 19-24.